COVID Testing

Facilitate the diagnosis of current and previous infection

Drug Candidate Evaluation
Product Development
Clinical Services
Applications & Solutions

Testing

COVID-19 Testing Capabilities at Frontage

Frontage laboratory is committed to support our local community and world-wide clinical trial in the battle of COVID-19.  Our highly experienced team is actively working to develop COVID-19 related testing capabilities. These tests will facilitate the diagnosis of current and previous COVID-19 infection.  The semi-quantitative IgG assay will help evaluate the titer of the COVID-19 antibody post infection or vaccine.

Click Here For Individual Testing

Click Here To Request Information On Group Contract Testing

 


Medical Diagnostics

SARS-CoV-2 Nucleic Acid Testing and Environmental Specimens

Platforms

Samples

Methodology

Diasorin Liaison MDX Oral Pharyngeal swab Direct Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
Thermo Fisher Taq Path Multiplex Diagnostic Platform Nasal Pharyngeal swab
Bronchioalveolar lavage
Environmental Sample

COVID-19 Antibodies Assay  

Platforms

Samples

Methodology

Testing Strips (qualitative IgG and IgM) Serum/Plasma/Whole Blood Lateral Flow Immunoassay
Automated Test (semi-quantitative IgG, in development) Serum/Plasma/Whole Blood Immunoassay

Clinical Trials:

Any clinical trial with requirements for testing of any of the above specimens

Turnaround time:

24 – 48 Hours (From specimen receiving to reporting)


COVID-19 Workforce Testing (Employee Testing or Return to Work/School Testing)


Frontage Laboratories is committed to providing our scientific expertise and services towards our customer’s solutions. We are fully operational and ready to assist in any capacity. For further questions about any of our COVID-19 capabilities, please contact us via email below.